Vidence, 2bPrecise partner on precision oncology

By The Science Advisory Board staff writers

October 27, 2020 -- Oncology informatics firm Vidence has signed on with 2bPrecise to use its data delivery system for precision medicine.

The partnership, which aims to make it easier for Vidence's Consortium Fellows network to access genomic information at the point of care and advance the practice of precision oncology, will result in integration of Vidence's Scimon technology platform with 2bPrecise's cloud-based data delivery system for providers.

OneOncology launches OneR, precision oncology research network
OneOncology has formed a subsidiary named OneOncology Research Network (OneR) as a national nonexclusive clinical trial site management organization to...
Illumina Accelerator announces new genomics startups
Illumina has chosen seven companies to join the first global cohort of Illumina Accelerator, its startup incubator that partners with entrepreneurs to...
Indivumed, Personalis partner on personalized oncology therapies
Indivumed and Personalis are joining forces in a collaboration aimed at enabling personalized oncology treatments.

Copyright © 2020

Register below for our weekly Letter from the Editor to receive the latest Science news and insights.
Festival of Genomics & Biodata
January 28-29, 2021
London, Greater London United Kingdom
Lab of the Future USA
May 11-12, 2021
Boston, Massachusetts United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter